A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients (vol 45, 102037, 2021)

• Type: Other Publications
• Date: 2021

Authors

Deus, CM (Author) Other; Pereira, SP (Author) Other; Cunha Oliveira, T (Author) Other; Teixeira, J (Author) Other; Simoes, RF (Author) Other; Fernando Cagide (Author) FCUP; Benfeito, S (Author) Other; Fernanda Borges (Author) FCUP; Raimundo, N (Author) Other; Oliveira, PJ (Author) Other

Other information

Authenticus ID: P-00V-PY5

DOI: 10.1016/j.redox.2021.102117

Abstract (EN): 2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.

Language: English

Type (Professor's evaluation): Scientific